Torno Capital’s Aquestive Therapeutics AQST Stock Holding History

Torno Capital’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,200	Closed	-$19.4K	–	149
2024 Q3	$20.9K	Buy	+4,200	New	+$16.3K	﹤0.01%	202

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Torno Capital's AQST Position: Q4 2024 in Review

Torno Capital sold out of Aquestive Therapeutics (AQST) in Q4 2024, closing a stake of 4,200 shares — an estimated $19.4K sold.

Torno Capital first reported a position in AQST in Q3 2024 and held it in 1 quarter. The position peaked at $20.9K in Q3 2024. 114 funds tracked by Wall St. Rank hold AQST as of Q4 2024.

Torno Capital reported no remaining Aquestive Therapeutics position as of Q4 2024 after selling out during the quarter.
Torno Capital sold 4,200 Aquestive Therapeutics shares in Q4 2024, an estimated $19.4K.
Torno Capital first reported a position in Aquestive Therapeutics in Q3 2024 and held it in 1 quarter.
Torno Capital's Aquestive Therapeutics position peaked at $20.9K in Q3 2024.
114 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q4 2024.

Based on Torno Capital's 13F filing for Q4 2024, filed 14 Feb 2025.